ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1396	National Cancer Institute	Html	en	Levels of Evidence for Adult and Pediatric Cancer Treatment Studies (PDQ®)–Health Professional Version	Information about how to weigh the strength of the evidence obtained in different kinds of cancer treatment studies.	study allocations 0.55994 stronger conclusions 0.590358 randomized studies 0.798135 strength 0.75642 evidence 0.657795 study allocation 0.562189 clinical trials 0.717908 randomized study designs 0.766704 small systematic errors 0.589877 case-control studies 0.668928 PDQ editorial boards 0.679562 randomized trial 0.636458 individual studies 0.60263 response rate 0.616842 case-only series 0.70041 study design 0.888134 observational study designs 0.736094 PDQ Adult Treatment 0.665736 nonconsecutive cases 0.672159 PDQ Adult Cancer 0.655778 therapeutic strategy 0.618175 tumor response rate 0.613151 consecutive series 0.605201 Treatment Editorial Board 0.756511	explicit prospective hypotheses 0.587622 internal-control study subjects 0.746476 internal comparison group 0.725592 patient selection 0.600103 different cut points 0.60745 nonblinded randomized study 0.746604 study designs 0.92108 case series 0.614267 clinical trial—to case 0.64839 study arms 0.543205 PDQ Pediatric Treatment 0.659091 statistically significant results 0.596562 PDQ Pediatric Cancer 0.649154 series experiences 0.541012 clinical experiences 0.670302 different expert panels 0.607615 overall strength 0.584647 definable population 0.605214 study results 0.54495 previously conducted studies 0.628589 Cancer Treatment Summaries 0.759718 clinical studies 0.588362 population-based studies 0.62839 subset analyses 0.608887	CLICK HERE
1627	National Cancer Institute	Html	en	Liver (Hepatocellular) Cancer Prevention (PDQ®)–Patient Version	Hepatitis B and C, cirrhosis, and aflatoxin (poison from certain foods) are important risk factors for liver cancer. Learn about all of the risk factors for liver cancer and how to prevent liver cancer in this expert-reviewed summary.	hepatocellular) cancer: 0.61402 cancer risk factors 0.453697 Cancer prevention 0.626716 cancer prevention trials 0.490017 Hepatitis viruses 0.484698 hepatitis G virus 0.482783 cancer protective factor 0.439442 hepatitis B virus 0.48738 hepatitis infection 0.475638 hepatitis B. 0.524229 protective factors 0.458515 following PDQ summaries 0.446108 Cancer Information Service 0.428793 PDQ cancer information 0.628691 hepatitis E virus 0.48361 prevention clinical trials 0.441049 acute hepatitis 0.480938 Hepatitis A vaccine 0.480499 Prevention Editorial Board 0.442759 hepatitis C virus 0.486051 National Cancer Institute 0.524466 clinical trials 0.620519 especially hepatitis 0.473486	cancer information summary 0.538122 risk factors 0.559595 breast cancer prevention 0.419616 hepatitis virus 0.531251 hepatitis B vaccine 0.480451 liver cancer prevention 0.489862 Cancer Care page 0.416878 PDQ database 0.39653 hepatitis C. 0.481259 cancer risk factor 0.462005 hepatitis 0.804007 NCI’s PDQ 0.403154 PDQ summary 0.417038 hepatitis A virus 0.488307 NCI PDQ cancer 0.479454 chronic hepatitis 0.527021 cancer clinical trials 0.440605 hepatitis D virus 0.484344 hepatitis B infection 0.473174 healthy liver tissue 0.433816 cancer information summaries 0.436678 comprehensive cancer information 0.436454 cancer 0.929112	CLICK HERE
1761	National Cancer Institute	Html	en	HIV Infection and Cancer Risk	A fact sheet that describes the increased risk of certain types of cancer by people infected with HIV.	HIV-infected persons 0.508754 Interagency HIV Study 0.502379 lung cancer 0.484047 B-cell non-Hodgkin lymphoma 0.458276 J. Hepatocellular cancer 0.468864 non-HIV cancer risk 0.494393 Cancer Specimen Resource 0.469635 HIV-infected populations 0.478653 AIDS Malignancy 0.457277 cervical cancer 0.693342 Cancer Match Study 0.479104 current HIV treatment 0.516027 cause liver cancer 0.489672 Shiels MS 0.582975 recent cancer trends 0.457251 Cancer Epidemiology 0.46223 cancers 0.670125 human immunodeficiency virus 0.500937 HIV-infected population 0.54327 HIV-infected people 0.947346 United States 0.521772 non–AIDS-defining cancers 0.549624 antiretroviral therapy 0.544479 non-Hodgkin lymphoma 0.547712 poorer cancer survival 0.482973	general population 0.519659 A. HIV infection 0.48948 Kaposi sarcoma 0.627254 anal cancers 0.515539 HIV-associated cancers 0.517566 AIDS-defining cancers 0.457988 National Cancer Institute 0.47979 substantially higher risk 0.462943 Silverberg MJ 0.555726 Hodgkin lymphoma 0.483616 AIDS Cancer Clinical 0.500517 higher risk 0.566781 HIV-infected individuals 0.743448 HIV-related cancers 0.456193 anal cancer 0.625604 HIV-infected women 0.50457 oral cavity/pharynx cancer 0.497269 cancer risk 0.617858 et al 0.549092 New England Journal 0.468444 cancer 0.93948 liver cancer 0.56236 appropriate cancer treatment 0.491194 HIV infection 0.611339	CLICK HERE
1814	National Cancer Institute	Html	es	Tratamiento del cáncer de esófago (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento del cáncer de esófago.	potentially operable carcinoma 0.227364 Compton CC 0.235729 gastric cardia carcinomas 0.224835 oesophageal cancer 0.276104 M0 TX 0.378744 largo plazo 0.224774 7th ed 0.235623 Oesophageal Cancer Followed 0.223828 Symptomatic gastroesophageal reflux 0.225069 ecografía endoscópica 0.322801 Estados Unidos 0.43962 mortalidad perioperatoria 0.229531 Natl Cancer Inst 0.232717 estadificación tnm 0.223626 La incidencia 0.230541 estadio iv 0.258573 M0 T2 0.809899 tumor.ampliar cáncer 0.321047 M0 T1 0.972287 Lerut A 0.228355 M0 T3 0.670603 estadio ib 0.273395 estadio ia 0.270617 células escamosas versus 0.290657 Van Cutsem E 0.252346	Estadio Grado Localización 0.256738 mucosa esofágica distal 0.27828 tumor.ampliar adenocarcinoma 0.241411 Cancer Staging Manual 0.279268 iia 1-x superior 0.228 Thorac Cardiovasc Surg 0.318859 estadio iiia 0.354448 PDQ Tratamiento 0.239147 New York 0.233171 invasive surgical staging 0.223534 estadio iiic 0.343305 estadio iia 0.319628 Cancer treatment 0.223659 Clin Oncol 0.262378 medio t2–3 0.237546 Byrd DR 0.234186 M1 TX 0.23325 American Joint Committee 0.2654 Thorac Surg 0.250251 M0 Tis 0.325056 positron emission tomography 0.377883 Am Coll Surg 0.230102 M0 T4a 0.550107 AJCC Cancer Staging 0.282666	CLICK HERE
1835	National Cancer Institute	Html	es	Tratamiento del mesotelioma maligno (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento del cáncer del mesiotelioma maligno.	advanced malignant 0.116955 Cancer Res Clin 0.143881 unresectable malignant mesothelioma 0.113438 malignant mesothelioma previously 0.112719 Lung Cancer Study 0.118498 Leukemia Group 0.124194 Venkatraman E 0.115582 therapy with induction 0.114339 Antman KH 0.111559 Vogelzang NJ 0.12467 systemic chemotherapy 0.119496 patients with mesothelioma 0.113972 Thorac Oncol 0.117632 malignant mesothelioma 0.548307 with induction chemotherapy 0.120652 cisplatino versus 0.116229 Res Clin Oncol 0.141606 mesotelioma sarcomatoide 0.113237 intraperitoneal chemotherapy as 0.127133 patients with 0.17944 Union Against Cancer 0.114155 chemotherapy followed 0.119996 cisplatin-based intraperitoneal chemotherapy 0.127819 Lung Cancer 0.119323 multimodality approach 0.111112	PDQ Síndromes cardiopulmonares 0.116256 pleural maligno difuso 0.117211 Rusch VW 0.116274 patients with malignant 0.151958 National Cancer Institute 0.112603 induction chemotherapy followed 0.11661 Thorac Cardiovasc Surg 0.13604 Trimodality therapy with 0.114339 malignant pleural mesothelioma 0.977908 malignant peritoneal mesothelioma 0.154368 Clin Oncol 0.739133 extrapleural pneumonectomy 0.187603 diagnosed pleural mesothelioma 0.118912 DeCamp M 0.110451 pleural mesothelioma using 0.118896 cisplatino pemetrexed 0.111439 chemotherapy as treatment 0.13551 treated patients with 0.113408 advanced malignant mesothelioma 0.112494 Mentzer SJ 0.110243 European Organization 0.127591 Thorac Surg 0.114739 diffuse malignant mesothelioma 0.138575 pleural malignant 0.119345	CLICK HERE
1908	National Cancer Institute	Html	es	Tratamiento de la leucemia mieloide aguda en adultos (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento de la leucemia mieloide aguda en adultos.	linfocítica aguda 0.505572 leucemia promielocítica aguda 0.536157 siguientes procedimientos 0.505247 células madre 0.703397 leucemia mielógena aguda 0.512482 posibles factores 0.501447 siguientes aspectos 0.5019 leucemia aguda 0.511873 radiación quizás 0.505162 leucemia linfoblástica aguda 0.535526 LMA quizás 0.505703 hueso compacto 0.505434 neoplasias mieloides 0.501631 rayos x 0.501258 enlace drugs approved 0.505977 Acute Myeloid Leukemia 0.506164 célula madre mieloide 0.516071 cáncer.ampliar aspiración 0.501565 líquido cefalorraquídeo 0.511938	punción espinal.Ampliar 0.501523 National Cancer Institute 0.501258 leucemia granulocítica aguda 0.512402 Instituto Nacional 0.502137 célula madre linfoide 0.510737 PDQ Tratamiento 0.503456 sustancia química benceno 0.502803 leucemia mielógena 0.513696 médula espinal.ampliar quimioterapia 0.50588 leucemia mieloblástica aguda 0.512403 sistema nervioso central 0.50789 Physician Data Query 0.504454 madre mieloides 0.518606 siguientes situaciones 0.504197 células madre mieloides 0.508803 leucemia mieloide aguda 0.995372 célula madre 0.532153 blastocito mieloide 0.505386 siguientes sumarios 0.503116	CLICK HERE
1964	National Cancer Institute	Html	es	Tratamiento del cáncer de uretra (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento del cáncer de uretra.	uretra distal 0.983772 siguientes procedimientos 0.582434 siguientes elementos 0.524145 siguientes aspectos 0.522333 proximal.ampliar anatomía 0.514787 enfermedad.ampliar ureteroscopía 0.522025 Physician Data Query 0.500221 VPH tipo 0.523805 túbulos renales 0.527052 siguientes tipos 0.512788	libre uso 0.498555 media pulgada 0.51317 rayos x 0.553518 sistema urinario masculino 0.542122 pequeño rulo 0.511879 Cancer Institute 0.497836 siguientes riesgos 0.497881 realidad células 0.521213 pelvis renal 0.642604 Institutos Nacionales 0.50085	CLICK HERE
2987	National Cancer Institute	Html	en	Secondhand Smoke	When you smoke, it doesn't just affect you. And it's not just irritating to those around you, it's deadly.	feet 0.409991 dangers 0.420271 Lung cancer 0.428942 good example 0.428021 non-smoker 0.407426 care staff 0.426607 nicotine affect 0.427281 babysitters 0.406286 body 0.411562 smoker 0.414092 children 0.431937 harms 0.407652 sure caretakers 0.428123 secondhand smoke 0.971613 non-smokers 0.43912 heart disease‚ 0.429635 Fact 0.410452 short time 0.429909 somebody 0.406088 health problems 0.428728 smokefree restaurants 0.432863 lung infections 0.428228 smoking indoors 0.445671 main way smoking 0.477206 Breathing problems 0.428866	indoor public places 0.450365 babies 0.424287 smokers 0.419121 air 0.417572 life 0.412446 Breathing secondhand smoke 0.5983 infant death syndrome 0.453829 smoking 0.508887 National Cancer Institute 0.448359 heart attack‚ 0.429618 kids 0.411336 quiz 0.411311 cigarette 0.405834 coughing‚ extra phlegm‚ 0.454984 bronchitis 0.405901 people 0.432125 home 0.416331 nannies 0.405803 severe attacks 0.428972 best thing 0.428251 shortness 0.406847 ear infections 0.428442 low birth weight 0.454001 family 0.425482	CLICK HERE
16650	National Cancer Institute	Html	en	IOTF Mentors: Track 1 and Track 2	While at FDA, fellows are assigned a mentor who is a senior member of FDA scientific review staff. Learn more about mentors for Tracks 1 and 2.	drug product review 0.763531 Clinical Evaluation 0.730644 Advisory Committee meetings 0.730511 Hematology Oncology Toxicology 0.80093 Oncology Drug Regulation 0.827479 FDA Office 0.747931 FDA scientific review 0.854344 pharmaceutical manufacturers 0.733082 Oncology Products Office 0.814936 research 0.757558 Biologics Evaluation 0.740263 clinical pharmacologists 0.727898 Regulatory training 0.800464 investigational new drugs 0.747261 Clinical Oncology Reviewer 0.848942 continued clinical activities 0.77796 clinical trials 0.899868 trial design 0.727681 Attend professional meetings 0.742121 multiple datasets/clinical trials 0.738642 Investigational New Drug 0.775585 single clinical trial 0.788427 new drug applications 0.86424 clinical outcome 0.778656 NDA review process 0.758002	clinical pharmacology 0.838285 oncologic product development 0.729454 Innovative clinical trial 0.816069 internal FDA meetings 0.79892 FDA 0.887939 Biologic License Applications 0.733421 clinical oncologists 0.919688 Innovative Quantitative Methods 0.737333 new drugs 0.799324 Drug Evaluation 0.758545 new computational methods 0.750069 Pivotal Trial Data 0.777331 NIH clinical center 0.785514 phase clinical oncology 0.913342 clinical oncology trials 0.923 oncology products 0.879348 oncology product development 0.777566 clinical trials design 0.798466 late phase trials 0.755358 gene therapies 0.850877 clinical trial data 0.865175 Oncology Drug Products 0.81665 data analysis methods 0.780168 research project 0.749995	CLICK HERE
16867	National Cancer Institute	Html	null	Cómo encontrar a un doctor o un establecimiento de tratamiento si usted tiene cáncer	Hoja informativa que ofrece sugerencias para escoger a un médico y un establecimiento para el tratamiento del cáncer.			CLICK HERE